ArticleCureus2026
Implementation of Ultrasound-Guided Musculoskeletal Injections in a South Trinidad Medical Practice: A Perspective From a Resource-Limited Setting.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Musculoskeletal pain (MSP) is a general term for pain varying by source, characterized into nociceptive (tissue pain), neuropathic (nerve pain), and nociplastic (centralized pain). It affects muscles, bones, joints, tendons, and ligaments due to multiple etiologies, including trauma, degenerative changes, or autoimmune and inflammatory disorders, presenting as either acute or chronic pain with symptoms such as sharp, dull, tingling, or burning sensations. It is a leading cause of disability globally, particularly in low and middle-income countries. We want to highlight a real-world implementation that aims to illustrate translational feasibility, and not a comparative efficacy trial on degenerative (wear and tear) conditions such as osteoarthritis and tendinous injuries. Ultrasound-guided musculoskeletal (MSK) injections offer a minimally invasive and accurate treatment option for these two conditions, especially in settings where patients can face barriers to surgical care. Traditionally, management of such cases includes analgesia, physiotherapy, and surgery. This article highlights the implementation of ultrasound-guided musculoskeletal injection procedures in a general medical and surgical clinical setting in southern Trinidad, including hyaluronic acid (HA), platelet-rich plasma (PRP), and diluted corticosteroid injections. Over the course of two years (2023-2025), a total of 115 adult patients with chronic MSP who had an unsatisfactory response to treatment with oral analgesics were treated under ultrasound guidance. The patients largely reported qualitative improvement in pain and increased functionality post-intervention. No major complications due to the procedures were observed. Through this perspective/observational experience, we do not aim to quantify the treatment effect sizes, but rather to bring to attention the practical procedural techniques, associated safety, potential workflow advantages, and practical considerations of ultrasound-guided musculoskeletal injections, thereby highlighting their use as a radiation-free, feasible, and efficient intermediate treatment option in resource-limited settings that have limited access to advanced imaging or surgical services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.